Clinical Trials Logo

mHealth clinical trials

View clinical trials related to mHealth.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05848557 Recruiting - Cervical Cancer Clinical Trials

mSaada: A Mobile Health Tool

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

In the R21 phase of this project, investigators will: (1) work with key stakeholders and local and international developers to finalize the mSaada platform, building on the existing prototype to add patient and specimen tracking functionality; and (2) carry out a pilot to identify the patient, provider and health system factors necessary to design a trial to evaluate mSaada effectiveness in assisting community health volunteer-led home-based HPV screening, and implementation factors. Investigators will carry out a six-month pilot of mSaada with community units in two health facilities providing HPV-based screening, and use performance metrics including system usage rates, workflow observations and qualitative data to guide the planning of a to determine effectiveness. In the R33 phase of the project, investigators plan to: (1) conduct an 18-month c-RCT across 12 health facilities to determine the impact of mSaada on cervical cancer screening uptake, treatment acquisition and cervical cancer knowledge levels among women in the community; and (2) measure the requisite implementation factors for mSaada effectiveness, sustainability, and scale-up. The rigorous study design will allow us to determine the clinical impact of mSaada, ensure the local and regional infrastructure has the capacity necessary for sustainability and develop strategies for widespread implementation and scale-up. Collaboration with key stakeholders from the Kenya Ministry of Health will facilitate the development of a long-term sustainability plan as the country moves toward HPV-based cervical cancer screening. Investigators anticipate the mSaada platform will play a pivotal role in facilitating the introduction of HPV-based screening programs that can reach women in settings with limited health care infrastructure.

NCT ID: NCT05608967 Recruiting - Prehabilitation Clinical Trials

Effect of a Prehabilitation Mobile Application Versus Standard of Care Before Colon Cancer Surgery.

PREHAPP
Start date: September 1, 2021
Phase:
Study type: Observational [Patient Registry]

Pilot study to evaluate the effect of prehabilitation programme through a mobile application PREHapp in colon cancer surgery. The objectives of this pilot study were to evaluate the usability of the PREHapp for people undergoing colon cancer surgery, estimate the effect of the app on functional recovery after surgery and to evaluate complications during the postoperative period after 4 weeks of follow-up.

NCT ID: NCT05042011 Recruiting - Covid19 Clinical Trials

Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study

Start date: March 1, 2021
Phase:
Study type: Observational

In order to improve routine immunization uptake during COVID-19 pandemic, and to understand the perceptions and barriers related to vaccine hesitancy and coverage during COVID 19 and to explore the need for COVID-19 vaccination, separately and as a part of routine immunization, the investigators will be using qualitative methodology to explore and understand the role of mHealth and social media interventions, that are most suitable in Pakistani context to improve vaccination coverage during COVID-19 pandemic.

NCT ID: NCT04917601 Recruiting - Childhood Obesity Clinical Trials

A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment

EurEvira
Start date: May 24, 2022
Phase: N/A
Study type: Interventional

Evira is a digital support system newly developed for treatment of childhood obesity. Through daily weighings at home using a special scale together with a message function in the Evira application, enabling fast and easy communication with the clinic, parents and the clinicians can easily follow the child's weight development. The purpose of this randomized controlled study is to evaluate the effect of adding Evira to the already locally used life-style treatment of childhood obesity.

NCT ID: NCT04793425 Recruiting - Telemedicine Clinical Trials

Mobile App and Digital System for Patients After Myocardial Infarction

afterAMI
Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The treatment of acute myocardial infarction (MI) in Poland is at the level of standardized European care. However, the first months after MI are crucial from the perspective of patient's prognosis. It is extremely important to take care of all cardiovascular risk factors. Mobile application (afterAMI) supported by web system is a novel telemedical tool created to support patient and physician during the process of cardiac rehabilitation. The application has educational model with focus on cardiovascular risk factors and lifestyle after MI. Moreover, there is a module to control vital signs like blood pressure, heart rate, weight and many others. Additionally, application will send reminders for better drug adherence. 100 patients will be recruited to take part in the study. All of which will be hospitalized at the 1st Department and Clinic of Cardiology because of the MI. The aim of the project is to study the impact of application-supported model of care with comparison to standard care. At the end of the study cardiovascular risk factors control will be analysed, as well as rehospitalizations, patient's knowledge regarding risk factors, return to work and quality of life. This will be a prospective, open-label, randomized, single-centre study. All 100 patients will be observed 6 months after discharge from the hospital. End points will be assessed during control visit 1- and 6-months after inclusion into the study. This project is an example of a telemedicine solution application into everyday practice, which is consistent with multiple international cardiac societies.

NCT ID: NCT04738669 Recruiting - mHealth Clinical Trials

Mhealth and Teach-Back Effectiveness In 30-Day Readmissions Reduction

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

The Study is a feasibility randomized controlled trial aiming to assess the feasibility of mHealth (voice call and SMS) and teach-back interventions on reducing the 30 days readmission rate in the patients enrolled in the Sehat Sahulat Programme (Prime Minister National Health Programme(PMNHP)). The prime objective of this study was to generate a proof of concept for the conduct of a definitive trial for the reduction in readmissions in PMNHP. A feasibility randomized controlled trial study consisted of three arms i.e intervention 1 (telephonic contact and text messages), intervention 2 (teach-back method) and control is planned in program beneficiaries of Islamabad, Pakistan. The trial is being carried out in the three hospitals of Islamabad and patients are being recruited as per the inclusion and exclusion criteria.

NCT ID: NCT04502004 Recruiting - Smoking Cessation Clinical Trials

Smoking Cessation in Hospitalized Patients Using an App

NoFumo+
Start date: November 14, 2019
Phase: N/A
Study type: Interventional

This study generates a new proposal for intensive intervention following the recommendations to quit smoking in hospitalized patients, providing intensive, accessible and individualized treatment, as well as long-term follow-up, thanks to new technologies. The main advantage that mhealth can bring to public health is cost-effectiveness, scalability and wide reach compared to traditional treatments. Rapid diffusion and remote outreach can impact traditional treatment programs, reduce waiting lists for tobacco visits, and increase quit rates, as well as reduce barriers to accessing smoking cessation programs, by location or time conflicts. Since the possibility of continuous face-to-face support is very limited, health interventions carried out through a smartphone can help avoid this situation. The study by Finkelstein and Me Cha (2016) justifies this line of intervention and solves the doubt about the feasibility of using the mobile phone to quit smoking in hospitalized patients, highlighting its usefulness for all patients regadless their age, gender, computer skills, income and educational level. -Can an App apply an intensive intervention to stop smoking in the hospitalized patient?

NCT ID: NCT04256109 Recruiting - Oral Health Clinical Trials

Women's Access to Mobile Phones and Willingness to Utilize mHealth Interventions for Oral Health Promotion in Egypt

Start date: January 11, 2020
Phase:
Study type: Observational

In 2019, it was reported that there were 27.9 million smart phone users and 93.7 million phone subscribers in Egypt. This means that mHealth (which is the use of mobile phones in delivering health-care and public health services) could be a major asset to delivering oral health education to the secluded rural areas or the more under privileged remote areas in the future. However, in order to employ mHealth effectively, it's essential to estimate the percentage of users who, not only have access to mobile technology, but are also willing to utilize mHealth interventions. It is also of great importance to understand the patients' preferences regarding its use. This is in order to tailor an intervention that satisfies their needs for oral health related services. Therefore the aim of this study is to determine the access of Egyptian women to mobile phones, as well as their willingness to utilize mHealth interventions for oral health promotion.